BridgeMD
New treatment option for Smoking Behavior
Official title A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
ClinicalTrials.gov ID: NCT07119489
What this study is testing
- What it's testing
- The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Smoke ≥1 cigarettes every day in the past 30 days per participant report.
- Smoked at least 100 cigarettes (5 packs) in lifetime.
- Confirmation of cancer diagnosis at any time.
- Patient encounter with an AHWFBCCC provider within the last two years.
- Age ≥ 18 years at the time of consent.
You likely can't join if
- Patients actively receiving external tobacco use counseling or using tobacco cessation medications.
- Prior experience with more than five sessions of DBT-ST.
- Medical or psychiatric conditions limiting compliance with study requirements including suspected or reported cognitive impairment.
- Self-reported use of any psychoactive substance [except marijuana and nicotine] within the last 30 days.
- Have active and severe suicidal ideation at time of eligibility assessment or suicide attempt within the past month.
See the full eligibility criteria
- Smoke ≥1 cigarettes every day in the past 30 days per participant report.
- Smoked at least 100 cigarettes (5 packs) in lifetime.
- Confirmation of cancer diagnosis at any time.
- Patient encounter with an AHWFBCCC provider within the last two years.
- Age ≥ 18 years at the time of consent.
- Ability to understand and willingness to sign an IRB-approved informed consent, in English, directly.
- Able and willing to participate in video conference.
- Patients actively receiving external tobacco use counseling or using tobacco cessation medications.
- Prior experience with more than five sessions of DBT-ST.
- Medical or psychiatric conditions limiting compliance with study requirements including suspected or reported cognitive impairment.
- Self-reported use of any psychoactive substance [except marijuana and nicotine] within the last 30 days.
- Have active and severe suicidal ideation at time of eligibility assessment or suicide attempt within the past month.
The study team makes the final eligibility decision.
Where it's taking place
- Charlotte, North Carolina, United States
- Winston-Salem, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Charlotte, North Carolina, United States; Winston-Salem, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.